Jefferson awarded $30M contract to develop Ebola vaccine

The National Institutes of Health has awarded a five-year contract worth up to $30 million to Thomas Jefferson University to prepare and test a vaccine formulation designed to protect against the Ebola, Sudan, Marburg and Lassa fever viruses. The National Institute of Allergy and Infectious Diseases, part of the NIH, made an initial award of $2.6 million to Jefferson for the global project that will be led by principal investigator Matthias Schnell, the chairman of Jefferson's department of microbiology…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news